Request for Covid-19 Impact Assessment of this Report

ICT & Media

E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • ALL3815943
  • 190 Pages
  • February 2020
  • ICT & Media
Download Sample    Get Discount   
 
Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patient’s health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients’ medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.

Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.

The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.

• Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.

• Porter’s five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.

• The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.

KEY MARKET SEGMENTS

By Component

• Solutions

• Services

By Deployment

• On-premise

• Cloud

By End User

• Hospitals

• Office-based Physicians

• Pharmaceuticals

By Region

• North America

o U.S.

o Canada

• Europe

o Germany

o France

o UK

o Rest of Europe

• Asia-Pacific

o Japan

o China

o India

o Rest of Asia-Pacific

• LAMEA

o Latin America

o Middle East

o Africa

KEY MARKET PLAYERS

• Allscripts Healthcare, LLC

• Athenahealth, Inc.

• Cerner Corporation

• Change Healthcare

• DrFirst.com, Inc.

• eClinicalWorks

• Epic Systems Corporation

• Medical Information Technology, Inc.

• Practice Fusion, Inc.

• Surescripts

CHAPTER 1: INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS FOR STAKEHOLDERS

1.3. KEY MARKET SEGMENTS

1.4. KEY MARKET PLAYERS

1.5. RESEARCH METHODOLOGY

1.5.1. Secondary research

1.5.2. Primary research

1.5.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS

2.1.1. Top impacting factors

2.1.2. Top investment pockets

2.2. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET

3.3. VALUE CHAIN ANALYSIS

3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Government initiatives and incentive programs

3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances

3.4.1.3. Need to curtail escalating healthcare costs

3.4.2. Restraints

3.4.2.1. High cost of systems

3.4.2.2. Security & workflow issues

3.4.3. Opportunities

3.4.3.1. Growth in the developing countries across Asia-Pacific

3.5. INDUSTRY ROADMAP OF E-PRESCRIBING

3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET

CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT

4.1. OVERVIEW

4.2. SOLUTIONS

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. SERVICES

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT

5.1. OVERVIEW

5.2. WEB & CLOUD-BASED

5.2.1. Key market trends, growth factors, and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market analysis, by country

5.3. ON-PREMISE

5.3.1. Key market trends, growth factors, and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market analysis, by country

CHAPTER 6: E-PRESCRIBING MARKET, BY END USER

6.1. OVERVIEW

6.2. HOSPITALS

6.2.1. Key market trends, growth factors, and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market analysis, by country

6.3. OFFICE-BASED PHYSICIANS

6.3.1. Key market trends, growth factors, and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market analysis, by country

6.4. PHARMACEUTICALS

6.4.1. Key market trends, growth factors, and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market analysis, by country

CHAPTER 7: E-PRESCRIBING MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast, by region

7.2. NORTH AMERICA

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. Market size and forecast, by component

7.2.3. Market size and forecast, by deployment

7.2.4. Market size and forecast, by end user

7.2.5. Market analysis, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by component

7.2.5.1.2. Market size and forecast, by deployment

7.2.5.1.3. Market size and forecast, by end user

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by component

7.2.5.2.2. Market size and forecast, by deployment

7.2.5.2.3. Market size and forecast, by end user

7.3. EUROPE

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Market size and forecast, by component

7.3.3. Market size and forecast, by deployment

7.3.4. Market size and forecast, by end user

7.3.5. Market analysis, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by component

7.3.5.1.2. Market size and forecast, by deployment

7.3.5.1.3. Market size and forecast, by end user

7.3.5.2. UK

7.3.5.2.1. Market size and forecast, by component

7.3.5.2.2. Market size and forecast, by deployment

7.3.5.2.3. Market size and forecast, by end user

7.3.5.3. France

7.3.5.3.1. Market size and forecast, by component

7.3.5.3.2. Market size and forecast, by deployment

7.3.5.3.3. Market size and forecast, by end user

7.3.5.4. Rest of Europe

7.3.5.4.1. Market size and forecast, by component

7.3.5.4.2. Market size and forecast, by deployment

7.3.5.4.3. Market size and forecast, by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Market size and forecast, by component

7.4.3. Market size and forecast, by deployment

7.4.4. Market size and forecast, by end user

7.4.5. Market analysis, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by component

7.4.5.1.2. Market size and forecast, by deployment

7.4.5.1.3. Market size and forecast, by end user

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by component

7.4.5.2.2. Market size and forecast, by deployment

7.4.5.2.3. Market size and forecast, by end user

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by component

7.4.5.3.2. Market size and forecast, by deployment

7.4.5.3.3. Market size and forecast, by end user

7.4.5.4. Rest of Asia-Pacific

7.4.5.4.1. Market size and forecast, by component

7.4.5.4.2. Market size and forecast, by deployment

7.4.5.4.3. Market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. Market size and forecast, by component

7.5.3. Market size and forecast, by deployment

7.5.4. Market size and forecast, by end user

7.5.5. Market analysis, by country

7.5.5.1. Latin America

7.5.5.1.1. Market size and forecast, by component

7.5.5.1.2. Market size and forecast, by deployment

7.5.5.1.3. Market size and forecast, by end user

7.5.5.2. Middle East

7.5.5.2.1. Market size and forecast, by component

7.5.5.2.2. Market size and forecast, by deployment

7.5.5.2.3. Market size and forecast, by end user

7.5.5.3. Africa

7.5.5.3.1. Market size and forecast, by component

7.5.5.3.2. Market size and forecast, by deployment

7.5.5.3.3. Market size and forecast, by end user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018

8.2. TOP WINNING STRATEGIES

8.3. KEY DEVELOPMENTS

8.3.1. Product launches

8.3.2. Partnership

8.3.3. Business expansion

8.3.4. Acquisition

8.3.5. Collaboration

8.4. PATENT ANALYSIS

8.4.1. By region (2016-2019)

8.4.2. By applicant

CHAPTER 9: COMPANY PROFILE

9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. R&D Expenditure

9.1.7. Business performance

9.1.8. Key strategic moves and developments

9.2. ATHENAHEALTH, INC.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Product portfolio

9.2.5. Key strategic moves and developments

9.3. CERNER CORPORATION

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Product portfolio

9.3.5. Business performance

9.3.6. Key strategic moves and developments

9.4. CHANGE HEALTHCARE

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Product portfolio

9.4.5. Key strategic moves and developments

9.5. DRFIRST

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Product portfolio

9.5.5. Key strategic moves and developments

9.6. ECLINICALWORKS

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Product portfolio

9.6.5. Key strategic moves and developments

9.7. EPIC SYSTEMS CORPORATION

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Product portfolio

9.7.5. Key strategic moves and developments

9.8. MEDICAL INFORMATION TECHNOLOGY, INC.

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Product portfolio

9.8.5. Key strategic moves and developments

9.9. PRACTICE FUSION, INC.

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Product portfolio

9.9.5. Key strategic moves and developments

9.10. SURESCRIPTS

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Product portfolio

9.10.5. Key strategic moves and developments

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

World Intelligent Virtual Assistant Market Opportunities and Forecasts, 2014 - 2020

Intelligent virtual assistant (IVA) is a next generation software solution that facilitates user interaction with PC, through internet, SMS, messenger and other interfaces. IVA systems use various interaction methods, which include text-to-text, speech-to-text, text-to-speech, and speech-to-speech, among others to assist users in executing their respective tasks. The ...

  • Publish Date: January 1, 2016
  • $5370
World Software Defined Networking Market - Opportunities and Forecasts, 2015-2022

Software defined networking (SDN) is a technology that creates a global view of network to provide centralized, intelligence-based network control by separating the control logic from off-device computer resources. This technology has redefined the networking ...

  • Publish Date: May 25, 2016
  • $5370
World Computer Numerical Control (CNC) Market - Opportunities and Forecasts, 2014-2022

Computer Numerical Control (CNC) machines are the fully-automated and sophisticated solution for metal working tools controlled by computers. These machines are the asset of machine tools industry owing to the profit gained by its application in the end-user i...

  • Publish Date: November 19, 2016
  • $5370